the derivatization reagent by means of a syringe, and the connecting reaction and separation capillaries are filled independently with the running buffer. the LOD for human transferrin after labelling with OPA is 5 amol. this means that the detection limits obtained with this system are comparable with those obtained with OPA after a pre-column labelling. in addition to this reactor device, two more or less related set-ups are described